Home Cart 0 Sign in  
X

[ CAS No. 38707-70-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 38707-70-9
Chemical Structure| 38707-70-9
Chemical Structure| 38707-70-9
Structure of 38707-70-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 38707-70-9 ]

Related Doc. of [ 38707-70-9 ]

Alternatived Products of [ 38707-70-9 ]

Product Details of [ 38707-70-9 ]

CAS No. :38707-70-9 MDL No. :MFCD00805837
Formula : C10H7NO Boiling Point : -
Linear Structure Formula :- InChI Key :OVZQVGZERAFSPI-UHFFFAOYSA-N
M.W : 157.17 Pubchem ID :170103
Synonyms :

Calculated chemistry of [ 38707-70-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.13
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.61
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 1.14
Log Po/w (SILICOS-IT) : 2.62
Consensus Log Po/w : 1.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.58
Solubility : 0.412 mg/ml ; 0.00262 mol/l
Class : Soluble
Log S (Ali) : -2.18
Solubility : 1.03 mg/ml ; 0.00656 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.63
Solubility : 0.0364 mg/ml ; 0.000232 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 38707-70-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38707-70-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38707-70-9 ]
  • Downstream synthetic route of [ 38707-70-9 ]

[ 38707-70-9 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 16032-35-2 ]
  • [ 38707-70-9 ]
YieldReaction ConditionsOperation in experiment
91% at 20℃; for 4 h; General procedure: To a mixture of alcohol in dry DMSO (10 volume) was added 1 equiv of polymer bromide and the reaction mixture was stirred at room temperature for a given period of time (Table 1). After the completion of the reaction, the reaction mixture was filtered and the polymer bed washed with DMSO. Combined DMSO layers were quenched with ice-water mixture and extracted with ether. The ether layer was given water wash, brine wash, dried over anhydrous sodium sulphate, and concentrated to get the pure carbonyl compounds. All the products were characterized by NMR and MS analysis.
79% With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In dimethyl sulfoxide A solution of 0.50 g (3.5 mmol) of 8-methylquinoline (21), 1.87 g (10.5 mmol) of N-bromosuccinamide (NBS), and 50 mg (0.3 mmol) of azobisisobutyronitrile (AIBN) in dichloroethane was refluxed under argon for 30 h. The reaction mixture was diluted with 150 mL dichloromethane, washed three times with 2 N NaOH, and brine, dried (MgSO4), and concentrated. The residue was refluxed in 50 mL of water for 4 h, cooled to 25 °C, diluted with 50 mL of 2 N NaOH, and extracted three times with diethyl ether. The combined organic layer was washed with brine, dried (MgSO4), concentrated, and column chromatographed on silica gel using a gradient mixture of hexane and diethyl ether as eluant to give 0.20 g (37percent yield) of 1613 and 0.30 g (53percent yield) of 2222 as solids. Compound 22 was converted to compound 16 by treating with IBX and DMSO in 79 percent yield. Compound 16: 1H NMR δ 11.45 (s, 1 H), 9.04 (dd, J = 4.3, 1.9 Hz, 1 H), 8.32 (dd, J = 7.0, 1.6 Hz, 1 H), 8.24 (dd, J = 8.4, 1.8 Hz, 1 H), 8.08 (dd, J = 8.2, 1.6 Hz, 1 H), 7.67 (t, J = 7.6 Hz, 1 H), 7.51 (dd, J = 8.4, 4.1 Hz, 1 H); 13C NMR δ 192.8, 151.5, 147.8, 136.5, 134.4, 131.9, 129.5, 128.5, 126.4, 122.0. MS (electrospray ionization) m/z 158.0 (M+H+), 128.1.
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 51, p. 6971 - 6973
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 10, p. 3480 - 3484
[3] Angewandte Chemie - International Edition, 2016, vol. 55, # 31, p. 9084 - 9087[4] Angew. Chem., 2016, vol. 128, # 31, p. 9230 - 9233,4
  • 2
  • [ 16567-18-3 ]
  • [ 68-12-2 ]
  • [ 38707-70-9 ]
YieldReaction ConditionsOperation in experiment
53% With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667 h; To a solution of 13a (100 mg, 0.48 mmol) in dry THF (1.5 mL) at -78 °C nBuLi (2.5 M in n-hexane, 300 μL, 0.72 mmol) was added dropwise.
The resulting solution turned to red and DMF (192 μL, 2.49 mmol) was added.
After 10 min at -78 °C the mixture was quenched with water.
The reaction was poured into a saturated aqueous solution of NaHCO3 (10 mL) and extracted with EtOAc (3 * 10 mL).
The combined organic layers were dried over anhydrous sodium sulfate, filtered and concentrated.
The residue was purified by flash chromatography on silica gel (10percent EtOAc in n-hexane) to afford the title compound as a yellow solid (53percent yield).
1H NMR (CDCl3, 300 MHz) δ 11.44 (s, 1H), 9.03 (dd, J1 = 1.8 Hz, J2 = 4.2 Hz, 1H), 8.31 (dd, J1 = 1.2 Hz, J2 = 7.2 Hz, 1H), 8.23 (dd, J1 = 1.8 Hz, J2 = 8.1 Hz, 1H), 8.08 (dd, J1 = 1.5 Hz, J2 = 8.4 Hz, 1H), 7.66 (t, J = 7.8 Hz, 1H), 7.50 (dd, J1 = 4.5 Hz, J2 = 8.4 Hz, 1H); ESI-MS m/z 158 [M+H]+; 180 [M+Na]+.
Reference: [1] European Journal of Medicinal Chemistry, 2019, p. 290 - 320
[2] Journal of Organic Chemistry, 1980, vol. 45, # 8, p. 1514 - 1515
  • 3
  • [ 68-12-2 ]
  • [ 38707-70-9 ]
YieldReaction ConditionsOperation in experiment
58%
Stage #1: With sec.-butyllithium In tetrahydrofuran; cyclohexane at -78℃; for 0.166667 h;
Stage #2: at -78℃; for 0.166667 h;
sec-Butyllithium (1.4 M in cyclohexane, 5. 0ml, 7. 0mmol) is added dropwise to a stirred solution of 8-bromoquinoline (1.29g, 6. 22mmol) and anhydrous tetrahydrofuran (22ml) at-78°C under nitrogen. The reaction is then stirred at-78°C for 10 min and then dimethylformamide (2. 5ml, 32.3mmol) is added. The reaction is then stirred for 10 min at-78°C and then quenched with water. The reaction is poured into saturated sodium bicarbonate (100ml) and extracted with ethyl acetate (100ml x3). The ethyl acetate is dried over sodium sulfate and then the sodium sulfate is filtered. The crude product is concentrated on a rotary evaporator and purified by flash chromatography on silica gel eluting with 20percent ethyl acetate/hexanes to yield (0.57g, 58percent) of quinoline-8- carboxaldehyde : mass spectrum (ion spray) : m/z=158. 0 (M+l) : 1H NMR (CDC13) : 8= 11.46 (1H, s), 9.06-9. 04 (1H, m), 8.34-8. 32 (1H, m), 8.26-8. 23 (1H, m), 8.11-8. 08 (1H, m), 7.70-7. 66 (1H, m), 7.53-7. 50 (1H, m).
Reference: [1] Patent: WO2005/92885, 2005, A1, . Location in patent: Page/Page column 62
  • 4
  • [ 611-32-5 ]
  • [ 38707-70-9 ]
Reference: [1] Chemistry of Natural Compounds, 1982, vol. 18, p. 598 - 600[2] Khimiya Prirodnykh Soedinenii, 1982, vol. 18, # 5, p. 633 - 635
[3] Chemistry - An Asian Journal, 2016, vol. 11, # 3, p. 385 - 389
[4] Journal of the American Chemical Society, 1997, vol. 119, # 38, p. 8991 - 9001
[5] Tetrahedron, 2004, vol. 60, # 51, p. 11889 - 11894
[6] Journal of Organic Chemistry, 1957, vol. 22, p. 217
[7] Zhurnal Obshchei Khimii, 1944, vol. 14, p. 330,334[8] Chem.Abstr., 1945, p. 4076
[9] Farmaco, Edizione Scientifica, 1951, vol. 6, p. 327,330
[10] Liebigs Annalen der Chemie, 1988, p. 455 - 464
[11] Journal of Organometallic Chemistry, 1987, vol. 319, p. 257 - 264
[12] Pakistan Journal of Scientific and Industrial Research, 1993, vol. 36, # 9, p. 357 - 359
[13] Journal of Organometallic Chemistry, 1983, vol. 243, # 1, p. 101 - 110
[14] Helvetica Chimica Acta, 1954, vol. 37, p. 90,93
[15] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 10, p. 3480 - 3484
[16] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 10, p. 3480 - 3484
[17] Angewandte Chemie - International Edition, 2016, vol. 55, # 31, p. 9084 - 9087[18] Angew. Chem., 2016, vol. 128, # 31, p. 9230 - 9233,4
  • 5
  • [ 86-59-9 ]
  • [ 38707-70-9 ]
Reference: [1] ACS Catalysis, 2018, vol. 8, # 12, p. 11134 - 11139
[2] Journal of the Chemical Society, 1943, p. 413,416
  • 6
  • [ 7496-46-0 ]
  • [ 38707-70-9 ]
  • [ 16032-35-2 ]
YieldReaction ConditionsOperation in experiment
0.2 g for 4 h; Reflux A solution of 0.50 g (3.5 mmol) of 8-methylquinoline (21), 1.87 g (10.5 mmol) of N-bromosuccinamide (NBS), and 50 mg (0.3 mmol) of azobisisobutyronitrile (AIBN) in dichloroethane was refluxed under argon for 30 h. The reaction mixture was diluted with 150 mL dichloromethane, washed three times with 2 N NaOH, and brine, dried (MgSO4), and concentrated. The residue was refluxed in 50 mL of water for 4 h, cooled to 25 °C, diluted with 50 mL of 2 N NaOH, and extracted three times with diethyl ether. The combined organic layer was washed with brine, dried (MgSO4), concentrated, and column chromatographed on silica gel using a gradient mixture of hexane and diethyl ether as eluant to give 0.20 g (37percent yield) of 1613 and 0.30 g (53percent yield) of 2222 as solids. Compound 22 was converted to compound 16 by treating with IBX and DMSO in 79 percent yield. Compound 16: 1H NMR δ 11.45 (s, 1 H), 9.04 (dd, J = 4.3, 1.9 Hz, 1 H), 8.32 (dd, J = 7.0, 1.6 Hz, 1 H), 8.24 (dd, J = 8.4, 1.8 Hz, 1 H), 8.08 (dd, J = 8.2, 1.6 Hz, 1 H), 7.67 (t, J = 7.6 Hz, 1 H), 7.51 (dd, J = 8.4, 4.1 Hz, 1 H); 13C NMR δ 192.8, 151.5, 147.8, 136.5, 134.4, 131.9, 129.5, 128.5, 126.4, 122.0. MS (electrospray ionization) m/z 158.0 (M+H+), 128.1.Compound 22: 1H NMR δ 8.77 (dd, J = 3.9, 1.2 Hz, 1 H), 8.07 (dd, J = 8.2, 1.2 Hz, 1 H), 7.65 (d, J = 8.2 Hz, 1 H), 7.55 (d, J = 7.0 Hz, 1 H), 7.40 (t, J = 7.6 Hz, 1 H), 7.32 (dd, J = 8.2, 4.3 Hz, 1 H), 5.20 (s, 2 H); 13C NMR δ 149.0, 146.8, 138.2, 136.7, 128.3, 127.5, 127.3, 126.4, 121.1, 64.2. MS (electrospray ionization) m/z 160.3 (M+H+), 142.0, 141.1.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 10, p. 3480 - 3484
  • 7
  • [ 85219-47-2 ]
  • [ 38707-70-9 ]
Reference: [1] Journal of Organometallic Chemistry, 1983, vol. 243, # 1, p. 101 - 110
[2] Helvetica Chimica Acta, 1954, vol. 37, p. 90,93
  • 8
  • [ 7496-46-0 ]
  • [ 38707-70-9 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1913, vol. 396, p. 47
[2] Organic Preparations and Procedures International, 2003, vol. 35, # 6, p. 627 - 630
[3] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 10, p. 3480 - 3484
  • 9
  • [ 615-36-1 ]
  • [ 38707-70-9 ]
Reference: [1] Journal of Organic Chemistry, 1980, vol. 45, # 8, p. 1514 - 1515
[2] European Journal of Medicinal Chemistry, 2019, p. 290 - 320
  • 10
  • [ 858784-66-4 ]
  • [ 38707-70-9 ]
Reference: [1] Journal of the Chemical Society, 1943, p. 413,416
  • 11
  • [ 79663-29-9 ]
  • [ 38707-70-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2016, vol. 55, # 31, p. 9084 - 9087[2] Angew. Chem., 2016, vol. 128, # 31, p. 9230 - 9233,4
  • 12
  • [ 578-66-5 ]
  • [ 38707-70-9 ]
Reference: [1] European Journal of Medicinal Chemistry, 2019, p. 290 - 320
  • 13
  • [ 215606-70-5 ]
  • [ 38707-70-9 ]
Reference: [1] Chemische Berichte, 1902, vol. 35, p. 1273
  • 14
  • [ 94127-04-5 ]
  • [ 38707-70-9 ]
Reference: [1] Chemische Berichte, 1902, vol. 35, p. 1273
  • 15
  • [ 25635-22-7 ]
  • [ 38707-70-9 ]
Reference: [1] Journal of the Chemical Society, 1943, p. 413,416
  • 16
  • [ 85949-81-1 ]
  • [ 38707-70-9 ]
Reference: [1] Journal of the Chemical Society, 1943, p. 413,416
  • 17
  • [ 95-53-4 ]
  • [ 38707-70-9 ]
Reference: [1] Farmaco, Edizione Scientifica, 1951, vol. 6, p. 327,330
  • 18
  • [ 215606-70-5 ]
  • [ 7697-37-2 ]
  • [ 38707-70-9 ]
Reference: [1] Chemische Berichte, 1902, vol. 35, p. 1273
  • 19
  • [ 38707-70-9 ]
  • [ 86-59-9 ]
Reference: [1] Chemische Berichte, 1902, vol. 35, p. 1273
[2] Journal of the American Chemical Society, 1951, vol. 73, p. 5622,5627
[3] Organic Preparations and Procedures International, 2003, vol. 35, # 6, p. 627 - 630
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38707-70-9 ]

Aldehydes

Chemical Structure| 127406-56-8

[ 127406-56-8 ]

4-(Pyridin-2-yl)benzaldehyde

Similarity: 0.93

Chemical Structure| 108166-03-6

[ 108166-03-6 ]

2-Methylquinoline-6-carbaldehyde

Similarity: 0.91

Chemical Structure| 13669-42-6

[ 13669-42-6 ]

Quinoline-3-carboxaldehyde

Similarity: 0.89

Chemical Structure| 5470-96-2

[ 5470-96-2 ]

Quinoline-2-carboxaldehyde

Similarity: 0.83

Chemical Structure| 791626-59-0

[ 791626-59-0 ]

2-Chloroquinoline-6-carbaldehyde

Similarity: 0.81

Related Parent Nucleus of
[ 38707-70-9 ]

Quinolines

Chemical Structure| 108166-03-6

[ 108166-03-6 ]

2-Methylquinoline-6-carbaldehyde

Similarity: 0.91

Chemical Structure| 56234-20-9

[ 56234-20-9 ]

1-(Quinolin-8-yl)ethanone

Similarity: 0.90

Chemical Structure| 13669-42-6

[ 13669-42-6 ]

Quinoline-3-carboxaldehyde

Similarity: 0.89

Chemical Structure| 55706-57-5

[ 55706-57-5 ]

6-Methylquinoline-8-carboxylic acid

Similarity: 0.83

Chemical Structure| 86-59-9

[ 86-59-9 ]

Quinoline-8-carboxylic acid

Similarity: 0.83